Bioanalysis

  • Bioanalysis
  • Altasciences Announces New Lab Expansion

     

    Altasciences is proud to announce the completion of a second expansion of its ligand binding laboratory to meet the high demand for quality bioanalytical services. The GLP, GCP laboratory was enlarged to include 52 benches for sample analysis, an enhanced space for cell culture and flow cytometry services, additional extraction rooms for handling all types of tissue matrices, a dedicated CL2 room for handling samples and RG2 material, a balance room for critical reagent and solution preparation, and an extraction space for an additional 50 analysts.

    With this expansion, Altasciences’ ligand binding assay tripled its square footage and will add to its employee base. Altasciences’ goal is to offer clients the opportunity to leverage the significant knowledge and industry experience of its team of scientific experts to develop strategic bioanalytical testing plans to complement its drug development programs.

    Altasciences uses innovative and cost-effective approaches to develop or customize ligand binding assays for the quantitative determination of biologics and small molecules therapeutic products. Altasciences continues to expand its immunogenicity, PK, oligonucleotide and biomarker testing to its already robust preclinical and clinical trial and bioanalysis testing capabilities.

    Click here to have a look at the new lab expansion.
     

    Newly Expanded - One Laboratory Sciences

    Have a question? Speak with an expert today.

    Altasciences is a forward-thinking, mid-size contract research organization offering pharmaceutical and biotechnology companies a proven, flexible approach to preclinical and clinical pharmacology studies, including formulation, manufacturing, and analytical services. For over 25 years, Altasciences has been partnering with sponsors to help support educated, faster, and more complete early drug development decisions. Altasciences’ integrated, full-service solutions include preclinical safety testing, clinical pharmacology and proof of concept, bioanalysis, program management, medical writing, biostatistics, clinical monitoring, and data management, all customizable to specific sponsor requirements. Altasciences helps sponsors get better drugs to the people who need them, faster.
     

    Real-Time PCR / Quantitative PCR

     

    Our scientific team works with you, in a collaborative approach, to develop, optimize, and validate your complex molecular assays using quantitative PCR (qPCR) to support your preclinical needs. Our experts are specialized in biodistribution and gene expression studies.

    Take a look inside our PCR lab

    Schedule a conversation with one of our experts to discuss our PCR platform.

    Email now

    Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.

    Have 5 minutes? Take a look at these scientific publications:

    Clinical Sample Kit Management

     

    From trial sites to our labs, Altasciences’ Material Management Team has over 25 years of experience supporting clinical trials around the globe. We make it easy with efficient collection, preparation and shipment of clinical samples.

    Each kit is adapted to your specific study needs, and allows for the storage and shipping of different matrices, such as plasma, urine, serum, and whole blood.

    Download our fact sheet to learn more about our capability or
    send us an e-mail and we will connect you with an expert within 24 hours.

    Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.

    You may also be interested in the following:

    Webpages:

    Fact Sheet:

    Bioanalytical Developments for the Analysis of Antisense Oligonucleotides

    Preclinical Strategies in Rodent Studies Using Volumetric Absorptive Microsampling (VAMS®)

    Expert Support for Your IND/CTA Requirements

    Partnering with Altasciences for your IND/CTA needs will ensure that your application to regulatory agencies moves forward as smoothly and efficiently as possible. To reach your milestones on time, we recommend setting up a meeting to consult with us at least six months before your required submission date.

    Contact our experts today.

    Altasciences can help you compile the key information necessary to approve your application request, including:

    • Animal pharmacology and toxicology studies to assess safety
    • Manufacturing processes to ensure consistent batches of the study drug
    • Clinical protocols and investigator information to assess tolerance and risk

    For a more detailed discussion of the regulatory planning process, consult our Preclinical Assessment Planning Guide.

    Altasciences’ Proactive Drug Development platform transforms the traditional outsourcing paradigm by providing you with expertly designed, customized roadmaps that seamlessly bring you from lead candidate selection to clinical proof of concept, and beyond.

    You may also be interested in the following:

    Using Anti-Drug-Antibody Screening Assay to Resolve Selectivity Issues in Toxicokinetic Ligand-Binding Assay

    Mitigation of On-Column Conversion of Ivabradine to Desmethylivabradine Metal Chelation With Citric Acid Modifier

    Dual Purpose of a Cell-Based Assay for an Agonist of the GLP-2 Receptor

    Development of an Oligonucleotide Drug Immunogenicity Assay: A Case for the Characterization of the Immune Response

    Subscribe to Bioanalysis